Drugs / Interferon (IFN) alpha
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00673361 | Mar 2007 → Jan 2009 | melanoma | Duke University | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon (IFN) alpha | “Interferon (IFN) alpha: 5 MIU/m\^2, daily, SC (subcutaneously), days 1-5” NCT00673361 ↗ |
| Known as | IFN alpha | “Interferon (IFN) alpha: 5 MIU/m\^2, daily, SC (subcutaneously), days 1-5” NCT00673361 ↗ |